Food and Drug Administration advisers unanimously recommended that the agency approve the first gene therapy for an inherited disease — a rare defect that causes blindness in children.
Friday, October 13, 2017
NPR News: FDA Panel Endorses Gene Therapy For A Form Of Childhood Blindness
FDA Panel Endorses Gene Therapy For A Form Of Childhood Blindness
Food and Drug Administration advisers unanimously recommended that the agency approve the first gene therapy for an inherited disease — a rare defect that causes blindness in children.
Food and Drug Administration advisers unanimously recommended that the agency approve the first gene therapy for an inherited disease — a rare defect that causes blindness in children.
Posts
0 comments:
Post a Comment